Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Compass Therapeutics, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Biological Products, (No Diagnostic Substances)
Prev close 1.86 · gapped above the open, never looked back. High/low 1.98 at 8:15 am ET, 1.86 at 3:45 pm ET.
Compass Therapeutics, Inc. has 6 disclosed suppliers and 1 disclosed customer. Each one is named in an SEC filing, either Compass Therapeutics, Inc.’s own annual report or the counterparty’s, and carries the sentence that discloses it.
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“This license revenue is reported net of a 15% sublicense royalty due ABL Bio (see Note 10 of the consolidated financial statements appearing in this Form 10-K for further information on this sublicense agreement).”
FILING10-K0001171843-25-001106cik 0001738021
“The licensing revenue consisted of a $1 million milestone payment from Elpiscience for completing a Phase 1 trial in China.”
FILING10-K0001171843-25-001106cik 0001738021
“This agreement relates to our license from Adimab for certain antibodies for development and commercialization as biopharmaceutical products, including our product candidate, CTX-471.”
FILING10-K0001171843-25-001106cik 0001738021
“In addition, the S-3 registration statement included a sales agreement with B. Riley Securities, Inc., pursuant to which we could offer and sell shares of our common stock having an aggregate of up to $75 million.”
FILING10-K0001171843-25-001106cik 0001738021
“We have funded our operations to date primarily with proceeds from private placements of preferred and common equity, an underwritten public offering and a PIPE offering, as well as sales under our at-the-market offering program pursuant to an Open Market Sale Agreement SM with Jefferies LLC.”
FILING10-K0001171843-25-001106cik 0001738021
“South Korean rights are held by Handok Pharmaceuticals, Inc. ("Handok") and China rights were out-licensed to Elpiscience Biopharmaceuticals Co., Limited ("Elpiscience").”
FILING10-K0001171843-26-001337cik 0001738021
“South Korean rights are held by Handok Pharmaceuticals, Inc. ("Handok") and China rights were out-licensed to Elpiscience Biopharmaceuticals Co., Limited ("Elpiscience").”
FILING10-K0001171843-26-001337cik 0001738021
Watchlist prices, news filtered to it, and its next report on your desk.
CMPX (Compass Therapeutics, Inc.) has 6 disclosed suppliers and 1 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.